![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Steensma David P. Komrokji Rami S. Stone Richard M. List Alan F. Garcia-Manero Guillermo Huber John M. Dennison Betsy Sekeres Mikkael A.
Publisher: Blackwell Publishing
E-ISSN: 1097-0142|120|11|1670-1676
ISSN: 0008-543X
Source: Cancer, Vol.120, Iss.11, 2014-06, pp. : 1670-1676
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Lenalidomide for Treatment of Myelodysplastic Syndromes
Current Pharmaceutical Design, Vol. 18, Iss. 22, 2012-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Arsenic trioxide for the treatment of myelodysplastic syndromes
By Vey Norbert
Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)